#1182
The Comparison of Maintenance and Induction Intravesical Chemotherapy in the Treatment of Non-Muscle Invasive Bladder Cancer
C. Chen1
1Chi-Mei Medical Center, Division of Urology, Department of Surgery, Tainan, Taiwan
Introduction:
We compared the utilization of maintenance and induction intravesical chemotherapy (IVC) in the treatment of non-muscle invasive bladder cancer (NMIBC) in the aspect of recurrence, progression, and survival.
Material and methods:
A total 45 maintenance IVC patients and 50 induction IVC patients were enrolled. They received whether Epirubicin or Mitomycin-c in protocol. We analyzed the recurrence- free survival(RFS), overall survival(OS) and complication in the follow-up of 4 years.
Results:
In comparison of maintenance and induction IVC, there was no significant difference in recurrence-free survival (p=0.82) and overall survival (p=0.45). No statically significant difference of complication (p=0.67) after IVC was found between the two groups.